{
  "question_stem": {
    "en": "A 55-year-old man comes to the office for follow-up. The patient was diagnosed with hypertension 3 weeks ago, and an ECG performed at that time showed features of left ventricular hypertrophy. He was subsequently referred for echocardiography. The patient feels well and has had no shortness of breath, fatigue, or leg swelling. He has no other medical conditions, takes no medications, and does not use tobacco, alcohol, or illicit drugs. Blood pressure is 155/90 mm Hg and pulse is 80/min. BMI is 35 kg/m². Physical examination shows normal jugular venous pressure. There are no lung crackles, heart gallops, or lower extremity edema. {{exhibit_1}} Which of the following patterns of chemical mediators is most likely present in this patient?",
    "zh": "一名55岁男性前来复诊。患者于3周前被诊断为高血压，当时进行的ECG显示左心室肥大的特征。随后，他被转诊进行超声心动图检查。患者感觉良好，没有呼吸急促、疲劳或腿部肿胀。他没有其他疾病，未服用任何药物，且不使用烟草、酒精或违禁药物。血压为155/90 mmHg，脉搏为80/分钟。BMI为35 kg/m²。体格检查显示颈静脉压正常。没有肺部啰音、奔马律或下肢水肿。{{exhibit_1}} 该患者最有可能出现以下哪种化学介质模式？"
  },
  "question": {
    "en": "Which of the following patterns of chemical mediators is most likely present in this patient?",
    "zh": "该患者最有可能出现以下哪种化学介质模式？"
  },
  "options": {
    "A": {
      "en": "Angiotensin II: Decreased, Norepinephrine: Decreased, Atrial natriuretic peptide: Decreased",
      "zh": "血管紧张素II：降低，去甲肾上腺素：降低，心房利钠肽：降低"
    },
    "B": {
      "en": "Angiotensin II: Decreased, Norepinephrine: Decreased, Atrial natriuretic peptide: Increased",
      "zh": "血管紧张素II：降低，去甲肾上腺素：降低，心房利钠肽：升高"
    },
    "C": {
      "en": "Angiotensin II: Decreased, Norepinephrine: Increased, Atrial natriuretic peptide: Increased",
      "zh": "血管紧张素II：降低，去甲肾上腺素：升高，心房利钠肽：升高"
    },
    "D": {
      "en": "Angiotensin II: Increased, Norepinephrine: Decreased, Atrial natriuretic peptide: Decreased",
      "zh": "血管紧张素II：升高，去甲肾上腺素：降低，心房利钠肽：降低"
    },
    "E": {
      "en": "Angiotensin II: Increased, Norepinephrine: Decreased, Atrial natriuretic peptide: Increased",
      "zh": "血管紧张素II：升高，去甲肾上腺素：降低，心房利钠肽：升高"
    },
    "F": {
      "en": "Angiotensin II: Increased, Norepinephrine: Increased, Atrial natriuretic peptide: Increased",
      "zh": "血管紧张素II：升高，去甲肾上腺素：升高，心房利钠肽：升高"
    }
  },
  "correct_answer": "F",
  "explanation": {
    "en": "This patient's echocardiography reveals a reduced left ventricular (LV) ejection fraction (<50%) in the absence of heart failure symptoms, a condition known as asymptomatic left ventricular systolic dysfunction. An early asymptomatic period is common in the progression of heart failure; it occurs in part due to compensatory eccentric hypertrophy in response to LV volume overload. In addition, neuronal mechanisms help maintain cardiac output and organ perfusion in the setting of declining cardiac function.\n\nEarly in the course of heart failure, small reductions in cardiac output lead to decreased stretch of aortic and carotid baroreceptors with consequent sympathetic nervous system activation (increased norepinephrine) to stimulate vasoconstriction, increased heart rate, and increased cardiac contractility. In addition, decreased renal perfusion stimulates the juxtaglomerular apparatus to increase renin secretion and activate the renin-angiotensin-aldosterone system (RAAS), leading to vasoconstriction via increased angiotensin II levels and salt and water retention via increased aldosterone levels. The volume retention (increased preload) and vasoconstriction (increased afterload) help maintain cardiac output and organ perfusion in the short term; however, the long-term effects are deleterious because increased hemodynamic stress and neuronal-induced cardiac remodeling eventually lead to decompensated heart failure.\n\nAtrial and ventricular myocardial stretch triggers increased atrial and brain natriuretic peptide secretion through separate neurohormonal pathways. These peptides stimulate vasodilation and salt and water excretion, counteracting the effects of the sympathetic nervous system and RAAS; however, the natriuretic pathways are eventually overwhelmed by the downward compensatory spiral. {{exhibit_2}}",
    "zh": "该患者的超声心动图显示左心室（LV）射血分数降低（<50%），但无心力衰竭症状，这种情况被称为无症状性左心室收缩功能障碍。在心力衰竭的进展过程中，早期无症状期很常见；部分原因是由于对左心室容量超负荷的代偿性向心肥大。此外，神经元机制有助于在心功能下降的情况下维持心输出量和器官灌注。\n\n在心力衰竭的早期，心输出量的小幅减少会导致主动脉和颈动脉压力感受器的牵张减弱，从而导致交感神经系统激活（去甲肾上腺素增加），以刺激血管收缩、心率增快和心肌收缩力增强。此外，肾灌注减少会刺激肾小球旁器，增加肾素分泌并激活肾素-血管紧张素-醛固酮系统（RAAS），从而通过增加血管紧张素II水平引起血管收缩，并通过增加醛固酮水平引起盐和水的潴留。容量潴留（前负荷增加）和血管收缩（后负荷增加）有助于在短期内维持心输出量和器官灌注；然而，长期影响是有害的，因为血流动力学应激增加和神经元诱导的心脏重塑最终导致失代偿性心力衰竭。\n\n心房和心室心肌牵张通过独立的神经激素途径触发心房和脑利钠肽分泌增加。这些肽刺激血管舒张和盐及水的排泄，抵消交感神经系统和RAAS的作用；然而，利钠肽途径最终会被向下的代偿螺旋所淹没。{{exhibit_2}}"
  },
  "summary": {
    "en": "The patient has asymptomatic left ventricular systolic dysfunction. In this condition, sympathetic nervous system activation and the renin-angiotensin-aldosterone system (RAAS) are increased, leading to increased norepinephrine and angiotensin II levels. Atrial natriuretic peptide is also increased due to myocardial stretch.",
    "zh": "该患者患有无症状性左心室收缩功能障碍。在这种情况下，交感神经系统激活和肾素-血管紧张素-醛固酮系统（RAAS）增加，导致去甲肾上腺素和血管紧张素II水平升高。由于心肌牵张，心房利钠肽也会增加。"
  },
  "tags": [
    "Pathophysiology",
    "Cardiovascular System",
    "Acute heart failure"
  ],
  "category": "CVS",
  "question_id": "15528",
  "has_exhibits": true,
  "exhibit_count": 2,
  "exhibit_files": [
    "image1.jpg",
    "image2.jpg"
  ],
  "folder_path": "C:\\Datas\\usmle\\step1\\clip\\CVS 23\\15528",
  "extracted_at": "2025-11-05T11:59:42.366585",
  "extraction_config": {
    "temperature": 0.3,
    "top_k": 20,
    "prompt_strategy": "minimal"
  },
  "translated_at": "2025-11-07T16:49:27.694709",
  "translation_model": "gemini-2.0-flash-lite",
  "embedding_model": "models/embedding-001",
  "embedding_dimension": 768
}